TITLE

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

AUTHOR(S)
Barbui, Corrado; Furukawa, Toshiaki A.; Cipriani, Andrea
PUB. DATE
January 2008
SOURCE
CMAJ: Canadian Medical Association Journal;1/29/2008, Vol. 178 Issue 3, p296
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Concern has been raised about the efficacy of antidepressant therapy for major depression in adults. We undertook a systematic review of published and unpublished clinical trial data to determine the effectiveness and acceptability of paroxetine. Methods: We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register, the Cochrane Central Register of Controlled Trials, the Glaxo-SmithKline Clinical Trial Register, MEDLINE and EMBASE up to December 2006. Published and unpublished randomized trials comparing paroxetine with placebo in adults with major depression were eligible for inclusion. We selected the proportion of patients who left a study early for any reason as the primary outcome measure because it represents a hard measure of treatment effectiveness and acceptability. Results: We included in our review 29 published and 11 unpublished clinical trials, with a total of 3704 patients who received paroxetine and 2687 who received with placebo. There was no difference between paroxetine and placebo in terms of the proportion of patients who left the study early for any reason (random effect relative risk [RR] 0.99, 99% confidence interval [CI] 0.88-1.11). Paroxetine was more effective than placebo, with fewer patients who did not experience improvement in symptoms of at least 50% (random effect RR 0.83, 99% CI 0.77-0.90). Significantly more patients in the paroxetine group than in the placebo group left their respective studies because of side effects (random effect RR 1.77, 95% CI 1.44-2.18) or experienced suicidal tendencies (odds ratio 2.55, 95% CI 1.17-5.54). Interpretation: Among adults with moderate to severe major depression in the clinical trials we reviewed, paroxetine was not superior to placebo in terms of overall treatment effectiveness and acceptability. These results were not biased by selective inclusion of published studies.
ACCESSION #
28794837

 

Related Articles

  • Editorial on hypothesis and objectives in clinical trials: superiority, equivalence and non-inferiority. Gonzalez, Claudio D.; Bolaños, Ricardo; de Sereday, Martha // Thrombosis Journal;2009, Vol. 7, p1 

    The article focuses on various issues related to hypothesis and objectives in clinical trials. It states that the majority of clinical trials are aimed to establish the superiority of an intervention regarding to an active control or placebo. Usually, the aim of a clinical trial is to show that...

  • Efficacy of St. John’s wort extract WS® 5570 in acute treatment of mild depression. Kasper, S.; Gastpar, M.; Müller, W. E; Volz, H. P.; Dienel, A.; Kieser, M.; Möller, H. J. // European Archives of Psychiatry & Clinical Neuroscience;Feb2008, Vol. 258 Issue 1, p59 

    Based on the original data from two double-blind, randomized, placebo-controlled clinical trials and the acute phase of a long-term study that investigated the antidepressant efficacy of St. John’s wort extract WS® 5570, we present a re-analysis of a subset of patients suffering from...

  • Joint Modeling of Efficacy, Dropout, and Tolerability in Flexible-Dose Trials: A Case Study in Depression. Russu, A; Marostica, E; De Nicolao, G; Hooker, A C; Poggesi, I; Gomeni, R; Zamuner, S // Clinical Pharmacology & Therapeutics;May2012, Vol. 91 Issue 5, p863 

    Many difficulties may arise during the modeling of the time course of Hamilton Rating Scale for Depression (HAMD) scores in clinical trials for the evaluation of antidepressant drugs: (i) flexible designs, used to increase the chance of selecting more efficacious doses, (ii) dropout events, and...

  • Placebo. McQuay, H. J.; Moore, R. A. // Postgraduate Medical Journal;Mar2005, Vol. 81 Issue 953, p155 

    Placebo, used here to mean an inert treatment given as if it was a real treatment, means lots of different things to different people. The structure of the article is that it begins by talking about the technical use of placebos in clinical trials, and the extent of the placebo response, then...

  • Efficacy and safety of Ayurvedic medicines: Recommending equivalence trial design and proposing safety index. Sarmukaddam, Sanjeev; Chopra, Arvind; Tillu, Girish // International Journal of Ayurveda Research;Jul2010, Vol. 1 Issue 3, p175 

    Ayurvedic drugs have begun to be evaluated in controlled clinical trials. The trials, often placebo controlled, are usually designed to demonstrate superiority. Though the results have been usually reported as encouraging, statistical significance has been elusive. In this melee to show...

  • Fluctuating baseline pain implicated in failure of clinical trials. Dolgin, Elie // Nature Medicine;Oct2010, Vol. 16 Issue 10, p1053 

    The article focuses on the assessment of discomfort and suffering in human clinical trials. It mentions the study conducted by Robert Palmer and colleagues which reviews the data from clinical trials that test the effectiveness of the drug milnacipran against placebo. Furthermore, it states that...

  • Terrible tractoration!! Watts, Geoff // New Scientist;1/8/2005, Vol. 185 Issue 2481, p48 

    The article reports that consequences of patent metallic tractors inventor, Elisha Perkins' hocus-pocus include an epic poem of majestic awfulness, a successful clinical trial, an early appreciation of the placebo effect and perhaps even the foundation of Yale School of Medicine. Patented in...

  • Caution on Head Injury Rx. Stephenson, Joan // JAMA: Journal of the American Medical Association;11/17/2004, Vol. 292 Issue 19, p2329 

    States the current treatment of severe head injuries with corticosteroids is dangerous, according to an international study. Finding of increased mortality within two weeks of hospital admission; Rationale for the treatment; Details of the CRASH trial which gave patients methylprednisolone or a...

  • Bias Control in Trials of Bodywork: A Review of Methodological Issues. Mehling, Wolf E.; DiBlasi, Zelda; Hecht, Frederick // Journal of Alternative & Complementary Medicine;Apr2005, Vol. 11 Issue 2, p333 

    To review and summarize the methodological challenges in clinical trials of bodywork or handsonmind–body therapies such as Feldenkraïs Method, Alexander Technique, Trager Work, Eutony, Body AwarenessTherapy, Breath Therapy, and Rolfing, and to discuss ways these challenges can be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics